This is a non-core endpoint: only basic statistics are computed.
Other special examinations and investigations of persons without complaint or reported diagnosis
Z21_OTHER_SPECIAL_EXAM_INVES_PERSONS_WO_COMPLA_REPOR_DIAGNOSIS
No definition available.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
124327
Check minimum number of events None
124327
Include endpoints None
124327
Remove individuals based on genotype QC
119737
Z21_OTHER_SPECIAL_EXAM_INVES_PERSONS_WO_COMPLA_REPOR_DIAGNOSIS
Control definitions
Control exclude
Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
Z[0-1]
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Other special examinations and investigations of persons without complaint or reported diagnosis
based on the number of shared cases.
Broader endpoints:
- Persons encountering health services for examination and investigation
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 119737 | 75949 | 43788 |
| Unadjusted prevalence (%) | 29.06 | 32.99 | 24.09 |
| Mean age at first event (years) | 50.98 | 48.28 | 55.66 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: Z21_OTHER_SPECIAL_EXAM_INVES_PERSONS_WO_COMPLA_REPOR_DIAGNOSIS – Other special examinations and investigations of persons without complaint or reported diagnosis
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Other special examinations and investigations of persons without complaint or reported diagnosis
↥Endpoint not on priority list, no data to show.